Delta 9 Announces Changes to Board of Directors
WINNIPEG, Sept. 10, 2018 /CNW/ – DELTA 9 CANNABIS INC. (TSXV: NINE) (“Delta 9” or the “Company”) is pleased to announce that Mr. Hugh H. Aird has joined the Company’s board of directors. Mr. Aird’s appointment follows the resignation of Anthony Jackson as a director of the Company.
Mr. Aird is a highly respected investment banker with a 35-year career that included more than 150 completed debt and equity financings and several merger and acquisition assignments with some of Canada’s top investment firms.
After attending Harvard University, Mr. Aird went on to work as vice-president of Dominion Securities from 1978 to 1985. Subsequently Mr. Aird founded and served as CEO of Great Lakes Capital Markets before becoming Chairman of Trilon Financial Corp. Mr. Aird served as Vice-Chairman of Midland Walwyn (later Merrill Lynch Canada) from 1995 to 2000, after which he left to take over as President and CEO of Berenson Minella (Canada) in 2001.
Mr. Aird also held several public and private board positions from 1990 to the present day, including among others Trilon Financial, Royal LePage Real Estate, Edelman Canada, and currently acts as Chair at Bainagowan Investments.
Delta 9 CFO Brent Bottomley stated that Mr. Aird brings a wealth of investment knowledge and operational excellence to the Company’s board of directors.
AS ONE OF CANADA’S MOST RESPECTED RELATIONSHIP BANKERS, HUGH HAS ALSO FOUNDED AND OPERATED MANY COMPANIES
AS OUR COMPANY CONTINUES TO GROW WITH THE ANTICIPATED LAUNCH OF FULL CANNABIS LEGALIZATION IN OCTOBER, HIS GUIDANCE IN BANKING, INVESTMENTS, CORPORATE GOVERNANCE AND OPERATIONS WILL BE CRITICAL TO DELTA 9’S SUCCESS
Mr. Aird said he is excited to be joining one of Canada’s leaders in the rapidly growing legal cannabis industry.
CANADA IS LEADING THE WAY IN THE COMMERCIALIZATION OF BOTH MEDICAL AND RECREATIONAL CANNABIS, AND DELTA 9 IS IN THE FOREFRONT AS A VERTICALLY INTEGRATED PRODUCER, RETAILER, AND EXPORTER OF CANNABIS
I LOOK FORWARD TO HELPING DELTA 9 GROW ACROSS CANADA AND INTO INTERNATIONAL MARKETS AS THIS INDUSTRY DEVELOPS
Bottomley also exchanged his thanks to Mr. Jackson for his service on the Delta 9 board of directors.
ANTHONY JOINED OUR BOARD AT A CRITICAL TIME IN OUR COMPANY’S DEVELOPMENT, AND WAS VERY HELPFUL IN GUIDING OUR TEAM AS WE MADE THE TRANSITION FROM A PRIVATELY HELD COMPANY TO A PUBLIC COMPANY ON THE TSX VENTURE EXCHANGE. WE ALL WANT TO EXTEND OUR THANKS FOR HIS ABLE ASSISTANCE OVER THIS VERY EVENTFUL YEAR
The appointment of Mr. Aird as a director of the Company remains subject to the approval of the TSX Venture Exchange.
About Delta 9 Cannabis Inc.
Delta 9 Cannabis was the fourth producer in Canada licensed to produce legal cannabis. Delta 9 now operates its wholly-owned subsidiary, Delta 9 Bio-Tech Inc., as a licensed producer of medical marijuana pursuant to the ACMPR and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 also owns 50 per cent of the 70,000 square foot Delta West facility in Alberta, and co-owns the Delta West Lifestyles cannabis retail operation. Delta 9’s shares trade on the TSX Venture Exchange under the symbol “NINE”.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Disclaimer for Forward-Looking Information
Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company’s future business plans and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward looking statements in this news release include statements relating to: (i) Delta 9’s expansion plans; and (ii) legalization of recreational cannabis in Canada. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including those risk factors set forth in the annual information form of Delta 9 dated May 31, 2018 which has been filed on SEDAR. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. These forward-looking statements are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.
SOURCE Delta 9 Cannabis Inc.